We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

AmpliPhi Signs Exclusive License With University of Leicester, UK

News   Oct 18, 2013

 
AmpliPhi Signs Exclusive License With University of Leicester, UK
 
 
 

RELATED ARTICLES

T Cell Study Uncovers New Hurdle for Developing Immunotherapies

News

There's an unexpected challenge to be overcome - T cell receptors can be more cross-reactive than previously thought.

READ MORE

Gout Get Outta Here

News

Researchers found a significant reduction in risk of gout attacks among patients who received the drug (canakinumab) that targets a key inflammatory molecule, suggesting a new target for therapeutic strategies to prevent gout attacks.

READ MORE

Cells Make Trade-offs in Fight Against Rhinovirus Infection

News

Mechanistic link between environmental exposures and susceptibility to the common cold revealed.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE